LumiraDx COVID-19 antigen tests detect Omicron variant, shares rise

LumiraDx

14/01/2022 12:50

** Shares of diagnostic co  LMDX.O  up ~12% at $10.33
premarket - set to open at their highest in nearly two months
    ** Co says results from ongoing testing and monitoring of
COVID-19 variants show its SARS-CoV-2 Antigen test detects
Omicron variant  urn:newsml:reuters.com:*:nPreDyKKja 
    ** Testing with live Omicron virus showed co's Antigen test
detects Omicron variant with comparable sensitivity to other
variants - LMDX
    ** LumiraDx SARS-CoV-2 Antigen test has received emergency
use authorization by FDA for use by authorized laboratories;
test kit which returns results in under 12 mins, includes
testing strip and small, portable instrument for running results
    ** Up to Thursday's close, stock had risen 3.59% YTD 
    

 (Reporting by Oishee Majumdar in Bengaluru)
 ((oishee.majumdar@thomsonreuters.com;))